Seker Ugur, Kaya Seval, Irtegun Kandemir Sevgi, Sener Dila, Unay Demirel Ozlem, Nergiz Yusuf
Department of Histology and Embryology, Harran University School of Medicine, Sanliurfa, Turkey.
Department of Histology and Embryology, Dicle University School of Medicine, Diyarbakir, Turkey.
Hepatol Forum. 2021 Nov 30;3(1):21-26. doi: 10.14744/hf.2021.2021.0035. eCollection 2022 Jan.
This study examined the effects of black cumin seed oil treatment on oxidative stress and the expression of radixin and moesin in the liver of experimental diabetic rats.
Eighteen rats were divided into 3 equal groups (control, diabetes, treatment). The control group was not exposed to any experimental treatment. Streptozotocin was administered to the rats in the diabetes and treatment groups. A 2.5 mL/kg dose of black cumin seed oil was administered daily for 56 days to the treatment group. At the conclusion of the experiment, the blood level of malondialdehyde (MDA) and glutathione (GSH) was measured. The expression level and the cellular distribution of radixin and moesin in the liver were analyzed.
The plasma MDA (3.05±0.45 nmol/mL) and GSH (78.49±20.45 μmol/L) levels in the diabetes group were significantly different (p<0.01) from the levels observed in the control group (MDA: 1.09±0.31 nmol/mL, GSH: 277.29±17.02 μmol/L) and the treatment group (MDA: 1.40±0.53 nmol/mL, GSH: 132.22±11.81 μmol/L). Immunohistochemistry and western blotting analyses indicated that while the level of radixin was not significantly between the groups (p>0.05) and moesin expression was significantly downregulated (p<0.05) in the experimental group, the treatment was ineffective.
The administered dose was sufficient to prevent oxidative stress, but was not sufficient to alleviate the effects of diabetes on moesin expression in hepatic sinusoidal cells.
本研究探讨了黑种草籽油处理对实验性糖尿病大鼠肝脏氧化应激以及根蛋白和埃兹蛋白表达的影响。
将18只大鼠分为3组,每组6只(对照组、糖尿病组、治疗组)。对照组未接受任何实验处理。糖尿病组和治疗组大鼠注射链脲佐菌素。治疗组大鼠每天按2.5 mL/kg剂量给予黑种草籽油,持续56天。实验结束时,测定丙二醛(MDA)和谷胱甘肽(GSH)的血药浓度。分析肝脏中根蛋白和埃兹蛋白的表达水平及细胞分布。
糖尿病组血浆MDA(3.05±0.45 nmol/mL)和GSH(78.49±20.45 μmol/L)水平与对照组(MDA:1.09±0.31 nmol/mL,GSH:277.29±17.02 μmol/L)和治疗组(MDA:1.40±0.53 nmol/mL,GSH:132.22±11.81 μmol/L)相比有显著差异(p<0.01)。免疫组织化学和蛋白质印迹分析表明,虽然各组间根蛋白水平无显著差异(p>0.05),且实验组中埃兹蛋白表达显著下调(p<0.05),但治疗无效。
给药剂量足以预防氧化应激,但不足以减轻糖尿病对肝窦细胞中埃兹蛋白表达的影响。